This study is comparing two different injection schedules for people with a honey bee sting allergy who are starting venom treatment.
Venom immunotherapy helps protect people who are severely allergic to bee stings from having a dangerous reaction in the future. Currently, starting this treatment involves many injections over several visits, which can be tiring and can prevent people from getting care.
In this study, researchers want to find out if starting directly at the full maintenance dose (4 injections) is as safe as the current intensive schedule (12 injections).
Anticipated enrolment close date: 31 December 2028
Who can take part
You may be eligible to participate if you:
- are an adult (18 years or older)
- have an allergy to honey bee venom and are planning to start venom immunotherapy
You may not be eligible to participate if you:
- are pregnant or breastfeeding
- take medications that weaken your immune system (such as prednisolone or methotrexate)
- take medications for a heart condition
- have other active or undiagnosed medical problems
- regularly donate blood and cannot pause donations for 12 weeks before and after the study
What's involved
Taking part in this study involves 5 hospital visits at The Royal Melbourne Hospital over about 12 weeks. During these visits, you will:
- attend an initial screening visit, where you will be asked questions about your health, have your weight checked, give a blood sample, and fill out a short health survey.
- receive the study treatment, where you will receive your bee venom injections. Staff will closely monitor your heart rate, blood pressure, and temperature for any allergic reactions.
- undergo blood tests during treatment visits.
- complete surveys and follow-ups assessments, where you will complete a short wellbeing survey at each visit, and a nurse will call you 2 to 3 days after each treatment to check how you are feeling.